Tuesday, 9 August 2022
  
Login

Australia's most trusted
source of pharma news

Tuesday, 09 August 2022
Listen to this story 
News

Boss out the door in CSL deal

Posted 3 August 2022 PM

Despite a three year stint on CSL's board before taking up the job of CEO at Vifor, it's been revealed that Abbas Hussain will not be welcomed back to the CSL-fold once the acquisition deal goes through. 

Hussain, will be out the door after almost exactly one year in the top job, according to details disclosed late yesterday confirming CSL's acquisition of Vifor.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Sales & Customer Relations (11)

Clinical & Medical, R&D (11)

Regulatory, Pharmacovigilance & QA (5)

Devices (1)

Other (15)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.